| 2001 | Fanger, C.M., Rauer, H., Neben, A.L., Miller, M.J., Rauer, H., Wulff, H., Rosa, J.C., Ganellin, C.R., Chandy, K.G. and M.D. Cahalan: Ca2+-activated K+ channels sustain Ca2+ signaling in T lymphocytes. In: Journal of Biological Chemistry, 2001, 12249-12256 |
|---|
| 2001 | Lanigan M.D., Pennington M.W., Lefievre Y., Rauer H. and R.S. Norton: Designed peptide analogues of the potassium channel blocker ShK toxin. In: Biochemistry, 2001, 15528-15537 |
|---|
| 2001 | Miller M.J., Rauer H., Tomita H., Rauer H., Gargus J..J, Gutman G.A., Cahalan M.D. and K.G. Chandy: Nuclear localization and dominant-negative suppression by a mutant SKCa3 N-terminal channel fragment identified in a patient with schizophrenia. In: Journal of Biological Chemistry, 2001, 27753-27756 |
|---|
| 1999 | Fanger, C.M., Ghanshani S., Logsdon N.J., Rauer H., Kalman K., Zhou J., Beckingham K., Chandy K.G., Cahalan M.D. and J. Aiyar: Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1. In: Journal of Biological Chemistry, 1999, 5746-5754 |
|---|
| 1999 | Rauer H. and S. Grissmer: The effect of deep pore mutations on the action of phenylalkyl-amines on the Kv1.3 potassium channel. In: British Journal of Pharmacology, 1999, 1065-1074 |
|---|
| 1999 | Hanson D.C., Nguyen A., Mather R.J., Rauer H., Koch K., Burgess L.E., Rizzi J.P., Donovan C.B., Bruns M.J., Canniff P.C., Cunningham A.C., Verdries K.A., Mena E., Kath J.C., Gutman G.A., Cahalan M.D., Grissmer S., and K.G. Chandy: UK-78,282, a Novel Piperidine Compound that Potently Blocks the Kv1.3 Voltage-Gated Potassium Channel and Inhibits Human T Cell Activation. In: British Journal of Pharmacology, 1999, 1707-1716 |
|---|
| 1998 | Wulff H., Rauer H., Duering T., Hanselmann C., Ruff K., Wrisch A., Grissmer S. and W. Hansel: Alkoxypsoralens- Novel nonpeptide blockers of Shaker- type K+-channels: Synthesis and photoreactivity. In: Journal of Medicinal Chemistry, 1998, 4542-4549 |
|---|
| 1998 | Jäger H., Rauer H., Nguyen A.N., Aiyar J., Chandy K.G. and S. Grissmer: Regulation of mammalian Shaker-related K+ channels: evidence for non-conducting closed and non-conducting inactivated states. In: Journal of Physiology, 1998, 291-301 |
|---|
| 1998 | Kalman K., Pennington M.W., Lanigan M.D., Nguyen A., Rauer H., Mahnir V., Paschetto K., Kem W.R., Grissmer S.,Gutman G.A., Christian E.P., Cahalan, M.D., Norton R.S. and K.G. Chandy: ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide. In: Journal of Biological Chemistry, 1998, 32697-32707 |
|---|
| 1996 | Nguyen A., Kath J. C., Hanson D.C., Biggers M.S., Cannif P.C., Donovan C.B., Mather R.J., Bruns M.J., Rauer H., Aiyar, J., Lepple-Wienhues A., Gutman G.A., Grissmer, S. Cahalan M.D. and K.G. Chandy: Novel nonpeptide agents potently block C-type inactivated conformation of Kv1.3 and suppress T cell activation. In: Molecular Pharmacology, 1996, 1672-1679 |
|---|
